Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Clinical trial NCT00611858 · TERMINATED
Trial details
- NCT number
- NCT00611858
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2012-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.